A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Craig Berman Verastem Medical Monitor
RAMP301@verastem.com
Study Director - Rachel Grisham, MD
GOG Foundation
Principal Investigator - Susana Banerjee, MBBS, MA, PhD
European Network of Gynaecological Oncological Trial Groups (ENGOT)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
106 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Hospital
Randwick, New South Wales, Australia
Yeh Chen Lee, MDRecruiting - Icon Cancer Centre Wesley
Auchenflower, Queensland, Australia
Jeffrey Goh, MDRecruiting - Cancer Research South Australia
Adelaide, South Australia, Australia
Meena Okera, MDRecruiting - Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Sumitra Ananda, MDRecruiting - Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
Tarek Meniawy, MDRecruiting
- Uza
Edegem, Belgium
Konstantinos Papadimitriou, MDRecruiting - University Hospital Ghent
Ghent, Belgium
Hannelore Denys, MDRecruiting
- Princess Margaret Cancer Center
Toronto, Ontario, Canada
Amit Oza, MDRecruiting - Centre Hospitalier de L'Universite de Montreal (chum)
Montreal, Quebec, Canada
Diane Provencher, MDRecruiting - Mcgill University Health Centre
Montreal, Quebec, Canada
Lucy Gilbert, MDRecruiting - British of Columbia
Vancouver, Canada
Anna Tinker, MDRecruiting
- Aalborg U.H
Aalborg, Denmark
Charlotte A Haslund, MDRecruiting
- Centre Hospitalier de Besançon
Besançon, France
Laura Mansi, MDRecruiting - Site Georges François Leclerc
Dijon, France
Jean-David Fumet, MDRecruiting - Centre Oscar Lambret
Lille, France
Cyril Abdeddaim, MDRecruiting - Centre Léon Bérard
Lyon, France
Isabelle Ray-Coquard, MDRecruiting - Institut Curie
Paris, France
Recruiting
- Agaplesion Markus Krankenhaus
Frankfurt am Main, Hesse, Germany
Marc Thill, MDRecruiting - Charité - Universitätsmedizin Berlin
Berlin, Germany
Radoslav Chekerov, MDRecruiting - Universitätsklinikum Carl Gustav Carus
Dresden, Germany
Pauline Wimberger, MDRecruiting - Kliniken Essen-Mitte
Essen, Germany
Philipp Harter, MDRecruiting - Umc Hamburg-Eppendorf
Hamburg, Germany
Barbara Schmalfeldt, MDRecruiting - Universitätsklinikum Mannheim Gmbh
Mannheim, Germany
Frederik Marmé, MDRecruiting - Universitätsfrauenkinik Ulm
Ulm, Germany
Fabienne Schochter, MDRecruiting
- St. James'S Hospital
Dublin, Ireland
Karen Cadoo, MDRecruiting
- Centro Di Riferimento Oncologico (cro)
Aviano, Italy
Michelle Bartoletti, MDRecruiting - Spedali Civili
Brescia, Italy
Germana Tognon, MDRecruiting - Ao Cannizzaro
Catania, Italy
Giuseppa Scandurra, MDRecruiting - European Institute of Oncology (ieo)
Milan, Italy
Nicoletta Columbo, MDRecruiting - Humanitas San Pio X
Milan, Italy
Domenica Lorusso, MDRecruiting - Istituto Nazionale Dei Tumori
Milan, Italy
Mara Mantiero, MDRecruiting - San Raffaele Hospital
Milan, Italy
Giorgia Mangili, MDRecruiting - Int Napoli Hospital
Naples, Italy
Sabrina Cecere, MDRecruiting - Istituto Oncologico Veneto (iov)
Padova, Italy
Valentina Guarneri, MDRecruiting - Irccs Gemelli
Roma, Italy
Vanda Salutari, MDRecruiting - Istituti Fisioterapici Ospitalieri
Rome, Italy
Savarese Antonella, MDRecruiting - S.C.D.U. Oncologia
Torino, Italy
Giorgio Valabrega, MDRecruiting
- the Mie University Hospital
Tsu, Mie-ken, Japan
Eiji Kondo, MDRecruiting - Aichi Cancer Center Hospital
Aichi, Nagoya, Japan
Shiro Suzuki, MDRecruiting - Tohoku University Hospital
Miyagi, Japan
Shogo ShigetaRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Mar 2024
- Primary completion
- 15 Oct 2028
- Completion
- 9 Feb 2031
- Last update posted
- 2 Apr 2026
- Registered enrollment
- 270
- Registry id
- NCT06072781
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.